ABSTRACT
INTRODUCTION
Pregnancy-associated plasma protein-A (PAPP-A) is a metalloproteinase produced by the placenta during pregnancy 1 . PAPP-A enhances the tissue availability of insulin-like growth factor-1 by cleavage of insulin-like growth factor-binding proteins and has been suggested to have several different functions, including matrix mineralization, microvascular endothelial cell proliferation and angiogenesis 2, 3 . Accordingly, low first-trimester PAPP-A levels are associated with a reduced number of capillaries and smaller capillary diameters in the placenta 4, 5 . First-trimester maternal PAPP-A levels are positively related to birth weight 6 , and this marker is used routinely in first-trimester screening, as low PAPP-A levels are associated with both chromosomal anomalies and adverse pregnancy outcomes, such as small-for-gestational age, preterm labor, pre-eclampsia and stillbirth 7 . PAPP-A is also detectable in non-pregnant individuals and is elevated in patients with acute coronary syndrome 8 , but the exact mechanistic function of PAPP-A in non-pregnant individuals or during pregnancy remains unclear 9 . Association between first-trimester maternal vascular function and fetal growth has been reported previously by our group and others [10] [11] [12] [13] . This raises the question of whether first-trimester maternal vascular function reflects placental conditions. Previous studies have established that vascular function of the brachial artery, as well as of the forearm skin microcirculation, reflects vascular conditions in other organs [14] [15] [16] [17] , but knowledge is lacking with respect to whether this also applies to the placenta. Therefore, the objective of the current study was to investigate the relationship between levels of circulating maternal PAPP-A and first-trimester maternal vascular function.
METHODS

Study design and subjects
The present cross-sectional investigation was part of a prospective longitudinal observational study on cardiovascular alterations during and after pregnancy 18 . The study was approved by the Regional Ethics Committee in Stockholm, Sweden and all subjects provided oral and written informed consent to participate. Data on the association between first-trimester maternal vascular function and fetal growth have been presented previously 13 . The current study included 60 healthy, non-smoking women undergoing routine first-trimester combined ultrasound and biochemical screening for Down syndrome. Inclusion criteria were nulliparity, singleton pregnancy, regular menstrual cycle and no fetal malformation observed at inclusion.
Measurements and calculations
Information on medical history, parity, height, weight and pregnancy outcome of all participants was collected from charts of the maternal healthcare units and from delivery wards. Birth-weight centile was calculated using a customized centile calculator 19 , taking into account the gestational age at delivery, maternal weight and height at booking, parity, ethnic group and sex of the neonate.
Vascular examinations of the brachial artery and the forearm skin microcirculation were performed on the same day, at gestational weeks 11-14. Brachial blood pressure was obtained as a mean of three readings, taken 1 min apart in the supine position, using an oscillometric device (OMRON 705IT, OMRON Healthcare, Kyoto, Japan) on the right arm with an appropriately sized cuff. Venous blood for PAPP-A measurements was collected in serum separator tubes, allowed to clot at room temperature for at least 30 min and centrifuged at 1700-2000 g for 10 min. Serum was separated and stored at 2-8
• C until analysis was performed on the same or the following day by immunoassay (AutoDelfia analyzer, PerkinElmer, Waltham, MA, USA). As PAPP-A levels are highly related to gestational age, PAPP-A multiples of the median (MoM) were calculated as a measure of the deviation of individual results from the median according to current gestational age. Further blood biochemistry analysis was performed according to standard procedures.
Forearm skin microvascular function
Endothelium-dependent and -independent forearm skin microvascular vasodilatation was assessed using laser Doppler perfusion imaging following iontophoretic administration of acetylcholine (ACh) and sodium nitroprusside (SNP) 20 . Electrode chambers (LI611 Drug Delivery Electrode Imaging, Perimed, Järfälla, Sweden) were attached to the volar side of the left forearm and filled with a small volume of either ACh or SNP. A battery-powered iontophoresis controller (Perilont 382b, Perimed) provided a direct current (0.1 mA for 60 s) for drug iontophoresis. Skin microvascular flux before, during and after iontophoresis was measured using laser Doppler perfusion imaging (PeriScan PIM II, Perimed) and expressed in arbitrary units (AU). Microvascular flux was recorded continuously up to 10 min and 14 min after iontophoresis of ACh and SNP, respectively, and peak microvascular flux was determined. Microvascular endothelial function index was calculated as peak ACh/peak SNP. Detailed information regarding the evaluation of potential confounders has been reported in previous publications 13, 18 .
Vascular function in the brachial artery
Forearm postischemic flow-mediated vasodilatation (FMD), which is considered to reflect endotheliumdependent vasodilatation, was assessed in the non-dominant arm, as previously described 21 . In brief, vasodilatation was induced by inflation of a pneumatic tourniquet placed around the forearm to a pressure of 250 mmHg for 5 min, followed by its release. Brachial artery blood flow and diameter were measured proximal to the cuff using a Vivid 7 Dimension ultrasound device with a 9-MHz linear transducer (GE Medical Systems, Horten, Norway). The mean values of three measurements of arterial diameter performed at end diastole were calculated at rest and at 30, 60 and 90 s after cuff release.
The maximum relative increase in diameter of the artery was taken as a measure of FMD. After a washout period of at least 10 min to regain stable resting conditions, 0.4 mg glyceryl trinitrate (GTN, Nitrolingual, G Pohl-Boskamp GmbH, Hohenlockstedt, Germany), given as sublingual spray, was used to assess endothelium-independent vasodilatation. Relative changes in brachial artery diameter following drug administration were calculated from rest to 4 min after administration. In order to assess endothelial function properly, the forearm endothelial function index was calculated as the ratio of the maximum relative increase in FMD/GTN 22 .
Statistical analysis
Results are presented as mean ± SD or with 95% CI, or as median and range if data were skewed. The Shapiro-Wilk test was used to test the distribution for normality. The independent sample Student's t-test was used for normally distributed and the Mann-Whitney U-test for non-normally distributed data. Univariate and multivariate analyses were performed using linear regression. Peak ACh/peak SNP was adjusted for age, serum total cholesterol, high-sensitivity C-reactive protein (hs-CRP), fasting plasma glucose and blood pressure. FMD was adjusted for age, serum total cholesterol, hs-CRP, blood pressure and brachial artery baseline diameter 23 . A two-sided P-value < 0.05 was considered significant. Statistical analysis was performed using the statistical package SPSS version 24 (SPSS Inc., Chicago, IL, USA).
RESULTS
Of the 60 women enrolled, 53 were included in the analysis as data for PAPP-A levels were missing in three cases, two women were excluded in mid-pregnancy due to lethal fetal malformations and two declined investigations due to discomfort. To explore the significance and potential confounders of first-trimester PAPP-A levels, levels were categorized as low (< median) or high (> median) PAPP-A MoM, as described previously 24 . Maternal characteristics at inclusion are shown in Table 1 . Two participants developed hypertension during pregnancy. Eight infants had a birth-weight centile < 10, in two of which it was < 5. No significant differences were seen between women with high and those with low PAPP-A levels with respect to age, height, weight or body mass index (Table 1) . Women with high levels of PAPP-A had higher hs-CRP (P = 0.029) and a tendency towards higher total cholesterol levels (P = 0.053) than women with low PAPP-A, whereas levels of serum creatinine, fasting plasma glucose and blood pressure were not significantly different between the two groups. On univariate analysis, PAPP-A was associated with hs-CRP (β = 0.046 (95% CI, 0.003-0.089), r 2 = 0.085, P = 0.046). Women with low PAPP-A levels gave birth at an earlier gestational age and had infants with a lower birth weight and birth-weight centile compared with women with high PAPP-A levels, although the differences did not reach statistical significance.
Forearm skin microvascular function
Skin microvascular variables are shown in Table 2 . Baseline microcirculation did not differ between women with low and those with high levels of PAPP-A, whereas peak ACh and ACh both showed a tendency to be higher in Table 1 Maternal characteristics and pregnancy outcome of 53 women according to level of pregnancy-associated plasma protein-A (PAPP-A), assessed during gestational weeks 11-14 Data are presented as mean ± SD or median (range). hs-CRP, high-sensitivity C-reactive protein; MoM; multiples of the median. Data are presented as mean ± SD. Endothelium-dependent forearm skin microvascular reactivity was assessed by response to administration of acetylcholine (ACh). Endothelium-independent forearm skin microvascular reactivity was assessed by response to administration of sodium nitroprusside (SNP). Endothelium-dependent vasodilatation of the brachial artery was evaluated by postischemic hyperemia-induced flow-mediated vasodilatation (FMD). Endothelium-independent vasodilatation of the brachial artery was assessed by response to sublingual intake of glyceryl trinitrate (GTN). Endothelial function index in skin microcirculation and in the forearm was calculated as peak ACh/peak SNP and FMD %/GTN %, respectively. AU, arbitrary units; MoM; multiples of the median. Skin microvascular function index calculated as peak acetylcholine (ACh)/peak sodium nitroprusside (SNP); peak ACh reflects endotheliumdependent forearm skin microvascular reactivity in response to administration of ACh; peak SNP reflects endothelium-independent forearm skin microvascular reactivity in response to administration of SNP. *Adjusted model includes age, serum total cholesterol, high-sensitivity C-reactive protein (hs-CRP), fasting plasma glucose and diastolic blood pressure. the group of women with high PAPP-A levels (P = 0.059 and P = 0.072, respectively). Endothelium-independent forearm skin microvascular vasodilation following administration of SNP (peak SNP) did not differ between the two groups, whereas endothelial function index (peak ACh/peak SNP) was significantly higher (P = 0.013) in the group of women with high levels as compared with those with low levels of PAPP-A. On univariate analysis, PAPP-A was associated with skin microvascular endothelial function index, i.e. peak ACh/peak SNP (β = 1.008 (95% CI, 0.34 to 1.68), r 2 = 0.17, P = 0.004) but not with peak ACh (β = 0.286 (95% CI, -0.085 to 0.658, r 2 = 0.05, P = 0.13) or peak SNP (β = -0.153 (95% CI, -0.525 to 0.219), r 2 = 0.02, P = 0.41) (Figure 1) . The association of PAPP-A with skin microvascular endothelial function index remained significant after adjusting for potential confounding factors (Table 3) .
Vascular function in the brachial artery
On univariate analysis, PAPP-A was inversely correlated with FMD (β = -0.052 (95% CI, -0.094 to -0.011), r 2 = 0.13, P = 0.014) but not with GTN (β = 0.0012 (95% CI, -0.048 to 0.072), r 2 = 0.01, P = 0.65). Forearm endothelial function index (i.e. FMD/GTN) was not associated with PAPP-A (β = -0.83 (95% CI -1.74 to 0.0766), r 2 = 0.10, P = 0.071) (Figure 1 ). The inverse correlation between PAPP-A and FMD was retained in multivariate analyses of PAPP-A adjusted for potential confounding factors (Table 4) . No correlation was found between skin microvascular function and vascular function in the brachial artery.
DISCUSSION
Main findings
This cross-sectional study of women in the first trimester of pregnancy appears to be the first to examine whether first-trimester maternal vascular function reflects placental circulation assessed indirectly by means of PAPP-A levels. We found a positive correlation between PAPP-A levels and skin microvascular endothelial function in the forearm and a negative correlation between PAPP-A and endothelium-dependent vasodilatation in the brachial artery. Our findings may seem conflicting at first glance. However, although both FMD and microvascular reactivity are independently associated with cardiovascular risk factors 15, 16, 25 , they represent very different aspects of vascular function. Although FMD and FMD/GTN reflect endothelial function in larger transport vessels 26 , skin microvascular reactivity merely reflects capillary circulation important for tissue oxygenation and nutrition. Accordingly, no relationship was found between measurements of skin microvascular reactivity and brachial artery reactivity.
Strengths and limitations
The strengths of the study include the novelty of the research, that maternal vascular function was investigated simultaneously in two maternal vascular beds and that indices of both endotheliumdependent and -independent vasodilatation were assessed. The latter is especially important during pregnancy when endothelium-independent vasodilatation, an important confounder, is markedly altered 18 . An important limitation of this study was that PAPP-A was considered a proxy for early placental function, but the accuracy of that can be questioned. However, in addition to the well-established relationship between low levels of PAPP-A and adverse pregnancy outcome, previous studies have also shown that first-trimester PAPP-A levels are significantly associated with placental thickness and morphology, placental vascularization and three-dimensional placental Doppler indices 4, 27, 28 . Another limitation of the study was its small sample size and that the majority of the participants had normal pregnancy outcome. Therefore, the results should be interpreted with caution and may not be extrapolated to pregnancies with complicated outcome.
Interpretation
Our results suggest that PAPP-A is associated with microvascular function. Placental microvascular function is of utmost importance for oxygenation and nutrition of the fetus 29 . Reduced capillary density (rarefaction) influences microcirculation and blood pressure with consequences for peripheral vascular resistance, tissue perfusion and metabolism 16 . We know that healthy individuals with hereditary diabetes have functional disturbances in skin microcirculation 30 , i.e. an impaired endothelium-dependent microvascular dilatation capacity. Accordingly, previous studies reported reduced PAPP-A levels in pregnant women with Type-2 diabetes as compared with healthy women 31, 32 . ACh-dependent skin microvascular responses have been related to insulin sensitivity and blood pressure in healthy individuals 33 . Reduced endothelium-dependent skin microvascular reactivity and low levels of PAPP-A in the first trimester may therefore be important early markers of metabolic disturbances and increased risk for impaired placental invasion and pregnancy complications.
Recent studies have shown that PAPP-A is elevated in a variety of conditions, such as cancer, atherosclerosis and end-stage renal disease 2, 8, 34, 35 . Studies on the association between FMD and PAPP-A are lacking; however, both PAPP-A and FMD are increased in the third trimester in pre-eclamptic pregnancies, as compared with normal pregnancies [36] [37] [38] . Furthermore, elevated PAPP-A levels were demonstrated in women 10 years after pre-eclamptic pregnancy 35 and serve as a biomarker for cardiovascular risk in non-pregnant individuals 8 . Hence, our observed association between reduced FMD and higher PAPP-A levels is in line with these findings. Accordingly, we also found that hs-CRP was higher in women with high PAPP-A levels. Coronary artery endothelial cells express PAPP-A when activated by proinflammatory cytokines 39 , and it has been suggested that elevated PAPP-A levels are important for preserving normal endothelial function 40, 41 . This might suggest that the explanation behind our results is compensatory, i.e. that microvascular dilatation is required as a compensatory mechanism to maintain sufficient circulation when larger artery constriction is present. Despite this, one previous study did not find any association between high first-trimester PAPP-A levels and adverse pregnancy outcome 42 . We believe that placental and maternal circulation have both shared and separate features that are equally important for sufficient fetal growth 43 . We hypothesize that first-trimester PAPP-A reflects mainly placental microvascular reactivity, whereas elevated third-trimester levels of PAPP-A found in pre-eclamptic pregnancies possibly reflect maternal large-vessel endothelial cell production of PAPP-A as a response to cardiovascular stress. This is supported indirectly by our findings of an inverse relationship between FMD and PAPP-A.
Conclusion
Our results suggest that first-trimester endotheliumdependent skin microvascular reactivity is positively associated with PAPP-A levels. We also found a correlation between higher PAPP-A levels and reduced endothelium-dependent vasodilation of the brachial artery. Our findings are novel and provide a better understanding of PAPP-A levels during pregnancy, and might suggest that first-trimester skin microvascular reactivity could be a marker for early placental function. Further studies are needed to confirm our findings and to evaluate whether first-trimester skin microvascular reactivity could be a useful early pregnancy marker of placental function.
